Year-over-year earnings per share growth for the last twelve months: Quest (DGX)

Quest Diagnostics - graphic logo of issuer DGX

Quest Diagnostics generates revenue through the mass administration of specialized and basic clinical tests for US healthcare facilities. The quarterly EPS dynamics clearly demonstrate capital allocation, while the value of 28.20 expresses the metric level. Its status as one of the market leaders allows the company to dictate terms to suppliers, while disciplined management ensures the development of its profitable molecular segment.

DGX: questdiagnostics.com Quarterly EPS earnings growth 07/04/2022 - 11/12/2026

Summary analytical data breakdowns for Quest Corp (DGX)

- company stock exchange capitalization indicators:
Fundamental company valuation:Quest Diagnostics Incorporated, DGX
Manufactured product of questdiagnostics.com

Quest Diagnostics leverages its laboratory network scale to optimize costs as test volumes grow. This indicator captures the quarterly net income per share trend, serving as a marker for the business's fundamental recovery. It is critical for investors to assess these growth rates to avoid purchasing the asset at a local peak. The quarterly EPS growth trajectory clearly demonstrates the effectiveness of the company's operating leverage.

Who Quest Diagnostics competes with

Agilent (A) - Year-over-year earnings per share growth for the last twelve months|ILMN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cologuard|RVTY - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months BIO (Bio-Rad Laboratories)|Quarterly EPS earnings growth anbio.com (NNNN)|Quarterly EPS earnings growth SHC (Sotera Health)|Quidel Corporation (QDEL) - Earnings per share growth in annualized terms for the last twelve months|OPK - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months CareDx, Inc CDNA|MRVI (Maravai LifeSciences) - Year-over-year net earnings per share growth for the last 12 months|FLGT: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months LAB|CTKB: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth OSUR|exagen.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MDXH (MDxHealth SA)|Year-over-year net earnings per share change for the last twelve months luciddx.com (LUCD)|Prenetics Global Ltd - Quarterly EPS earnings growth|IMDX - Quarterly EPS earnings growth|TRIB: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year ProPhase Labs Corp PRPH|Year-over-year earnings per share growth for the last twelve months Ainos, Inc.|Year-over-year earnings per share growth for the last 12 months CODX (codiagnostics.com)|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|BMRA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cardio Diagnostics Holdings CDIO|Year-over-year net earnings per share change for the last twelve months Onconetix Corporation (ONCO)|VRAX: Year-over-year net earnings per share growth for the last 12 months|bluejaydx.com - Year-over-year earnings per share growth rate for the last twelve months|AWH: Quarterly EPS earnings growth|AXDX - Year-over-year net earnings per share change for the last twelve months|CNTG (CENTOGENE) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo (ENZ)|Year-over-year earnings per share growth for the last twelve months Fresh2 Group Limited (FRES)|Year-over-year net earnings per share change for the last twelve months gtglabs.com|Quarterly EPS earnings growth ME (23andMe)|PMD: Year-over-year earnings per share growth for the last 12 months